A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.

por Joffe, J. K., Perren, T. J., Bradley, C., Primrose, J., Hallam, S., Ward, U., Illingworth, J. M., Selby, P. J.
Publicado 1997